Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash
Clinical trial NCT00656786 · COMPLETED
Trial details
- NCT number
- NCT00656786
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-03
- Primary completion
- 2009-12-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.